The behavior of PARP in PCa differentiation presented in the current study is in agreement with the results of Galande and Kohwi-Shigematsu that detected a strong BUR-specific binding activity of PARP in malignant, poorly differentiated breast carcinoma compared to well-differentiated tumor samples [38]. The gene discussed is PARP1; the disease is posterior cortical atrophy.